Humacyte Inc. Warrant (HUMAW) at a glance

Humacyte Inc. Warrant (HUMAW) is a Healthcare company. It trades at $0, with a -376.1% profit margin and revenue decline of 4.3%. It pays a 4039.4% dividend yield. Vestovix scores it 43/100 overall. Its strongest dimension is Income (92/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price
$0.00
Market cap
n/a
P/E ratio
n/a
Dividend yield
4039.41%
Beta
2.46
52-week range
$0.00 to $0.40
Vestovix Score43/ 100How this works
Value
48
Growth
34
Income
92
Safety
12
Momentum
12

Other Healthcare stocks

See all